A Safety Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium in Patients With Solid Tumors
Status:
Suspended
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine the safety and tolerability of elesclomol sodium at
escalating doses (ultimately identifying the maximum tolerated dose). This study will also
characterize the pharmacokinetics of elesclomol and evaluate its anti-tumor activity in
advanced solid tumors that are metastatic and unresectable.